Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells

被引:31
作者
Vera, Julio [1 ,2 ]
Raatz, Yvonne [3 ]
Wolkenhauer, Olaf [4 ]
Kottek, Tina [3 ]
Bhattacharya, Animesh [3 ]
Simon, Jan C. [3 ]
Kunz, Manfred [3 ]
机构
[1] Univ Hosp Erlangen, Dept Dermatol, Lab Syst Tumor Immunol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany
[3] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany
[4] Univ Rostock, Dept Syst Biol & Bioinformat, D-18057 Rostock, Germany
关键词
Tumour biology; Cell signalling; Cell cycle; Chk1; Wee1; DAMAGE-INDUCED APOPTOSIS; DNA-DAMAGE; MITOTIC CATASTROPHE; CHECKPOINT KINASES; CYCLE CHECKPOINTS; G(2) CHECKPOINT; P21; CANCER; P53; ATR;
D O I
10.1016/j.cellsig.2015.01.020
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the present report, the role of ATR-Chk1-Wee1 and ATM-Chk2-p53-p21 pathways in stress-induced cell cycle control is analysed in melanoma cells. Treatment of p53 wild-type melanoma cells with the genotoxic agent doxorubicin induces G2-M arrest, inhibitory phosphorylation of cell cycle kinase Cdc2 (CDK1) and enhanced expression of p53/p21. Wee1 inhibition under doxorubicin pulse-treatment reduces G2-M arrest and induces apoptosis. Inhibition of upstream kinase Chk1 under doxorubicin treatment almost completely abolishes stress-induced G2-M arrest and induces enhanced apoptosis. Interestingly, Chk1 inhibition alone even further increases apoptosis. While Chk1 inhibition alone almost completely abolishes G0-G1 arrest, combined treatment with doxorubicin re-establishes G0-G1 arrest. Moreover, Chk1 inhibition alone induces only a slight p53/p21 induction, while a strong induction of both proteins is observed by the combination with doxorubicin. These findings are suggestive for a particular role of p53/p21 in G0-G1, and Chkl in G0-G1 and G2-M arrest. In line with this, the p53-mutant SK-Mel-28 melanoma cells do not mount a significant G0-G1 arrest under combined doxorubicin and Chkl inhibitor treatment but rather show extensive apoptosis. Moreover, knockdown of p21 dramatically reduces stress-induced G0-G1 arrest under doxorubicin and Chkl inhibitor treatment accompanied by massive DNA damage and apoptosis induction. Treatment of melanoma cells with an inhibitor of Chk2 upstream kinase ATM and doxorubicin almost completely abolishes G0-G1 arrest. Taken together, both Chk1 and Wee1 are mediators of G2-M arrest, while p53, p21 and Chkl are mediators of G0-G1 arrest in melanoma cells. Combined treatment with chemotherapeutic agents such as doxorubicin and Chk1 inhibitors may help to overcome apoptosis resistance of p53-proficient melanoma cells. But treatment with Chkl inhibitor alone may even be more efficient. (C) 2015 Elsevier Inc All rights reserved.
引用
收藏
页码:951 / 960
页数:10
相关论文
共 47 条
[1]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]  
[Anonymous], J INVEST DERMATOL
[3]   A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint [J].
Beckerman, Rachel ;
Donner, Aaron J. ;
Mattia, Melissa ;
Peart, Melissa J. ;
Manley, James L. ;
Espinosa, Joaquin M. ;
Prives, Carol .
GENES & DEVELOPMENT, 2009, 23 (11) :1364-1377
[4]   Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair [J].
Berkovich, Elijahu ;
Monnat, Raymond J., Jr. ;
Kastan, Michael B. .
NATURE CELL BIOLOGY, 2007, 9 (06) :683-U137
[5]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[6]   Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects [J].
Garbe, Claus ;
Eigentler, Thomas K. ;
Keilholz, Ulrich ;
Hauschild, Axel ;
Kirkwood, John M. .
ONCOLOGIST, 2011, 16 (01) :5-24
[7]   p53 down-regulates CHK1 through p21 and the retinoblastoma protein [J].
Gottifredi, V ;
Karni-Schmidt, G ;
Shieh, SY ;
Prives, C .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (04) :1066-1076
[8]  
GUILLOUF C, 1995, ONCOGENE, V10, P2263
[9]   Cdk1-dependent regulation of the mitotic inhibitor Wee1 [J].
Harvey, SL ;
Charlet, A ;
Haas, W ;
Gygi, SP ;
Kellogg, DR .
CELL, 2005, 122 (03) :407-420
[10]   Small molecules and targeted therapies in distant metastatic disease [J].
Hersey, P. ;
Bastholt, L. ;
Chiarion-Sileni, V. ;
Cinat, G. ;
Dummer, R. ;
Eggermont, A. M. M. ;
Espinosa, E. ;
Hauschild, A. ;
Quirt, I. ;
Robert, C. ;
Schadendorf, D. .
ANNALS OF ONCOLOGY, 2009, 20 :35-40